TY - BOOK PY - 2009 DA - 2009// TI - IDF Diabetes Atlas ID - ref1 ER - TY - JOUR AU - Ferrante, D. AU - Linetzky, B. AU - Konfino, J. AU - King, A. AU - Virgolini, M. AU - Laspiur, S. PY - 2011 DA - 2011// TI - Encuesta Nacional de Factores de Riesgo 2009: evolución de la epidemia de enfermedades crónicas no transmisibles en Argentina. Estudio de corte transversal JO - Rev Argent Salud Pública VL - 2 ID - Ferrante2011 ER - TY - JOUR AU - Stratton, I. M. AU - Adler, A. I. AU - Neil, H. A. AU - Matthews, D. R. AU - Manley, S. E. AU - Cull, C. A. AU - Hadden, D. AU - Turner, R. C. AU - Holman, R. R. PY - 2000 DA - 2000// TI - Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7258.405 DO - 10.1136/bmj.321.7258.405 ID - Stratton2000 ER - TY - JOUR AU - Ong, K. L. AU - Cheung, B. M. Y. AU - Wong, L. Y. F. AU - Wat, N. M. AU - Tan, K. C. AU - Lam, K. S. PY - 2008 DA - 2008// TI - Prevalence, treatment and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004 JO - Ann Epidemiol VL - 18 UR - https://doi.org/10.1016/j.annepidem.2007.10.007 DO - 10.1016/j.annepidem.2007.10.007 ID - Ong2008 ER - TY - JOUR AU - Chan, J. C. AU - Gagliardino, J. J. AU - Baik, S. H. AU - Chantelot, J. M. AU - Ferreira, S. R. AU - Hancu, N. AU - Ilkova, H. AU - Ramachandran, A. AU - Aschner, P. PY - 2009 DA - 2009// TI - Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS) JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc08-0435 DO - 10.2337/dc08-0435 ID - Chan2009 ER - TY - JOUR AU - Ringborg, A. AU - Cropet, C. AU - Jönsson, B. AU - Gagliardino, J. J. AU - Ramachandran, A. AU - Lindgren, P. PY - 2009 DA - 2009// TI - Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS) JO - Int J Clin Pract VL - 63 UR - https://doi.org/10.1111/j.1742-1241.2009.02098.x DO - 10.1111/j.1742-1241.2009.02098.x ID - Ringborg2009 ER - TY - JOUR AU - Nathan, D. M. AU - Buse, J. B. AU - Davidson, M. B. AU - Ferrannini, E. AU - Holman, R. R. AU - Sherwin, R. AU - Zinman, B. PY - 2009 DA - 2009// TI - American Diabetes Association; European Association for Study of Diabetes: medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the american diabetes association and the european association for the study of diabetes JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc08-9025 DO - 10.2337/dc08-9025 ID - Nathan2009 ER - TY - JOUR AU - DeFronzo, R. A. PY - 1999 DA - 1999// TI - Pharmacologic therapy for type 2 diabetes mellitus JO - Ann Intern Med VL - 131 UR - https://doi.org/10.7326/0003-4819-131-4-199908170-00008 DO - 10.7326/0003-4819-131-4-199908170-00008 ID - DeFronzo1999 ER - TY - JOUR AU - Inzucchi, S. E. PY - 2002 DA - 2002// TI - Oral antihyperglycemic therapy for type 2 diabetes JO - JAMA VL - 287 UR - https://doi.org/10.1001/jama.287.3.360 DO - 10.1001/jama.287.3.360 ID - Inzucchi2002 ER - TY - JOUR AU - Charpentier, G. PY - 2002 DA - 2002// TI - Oral combination therapy for type 2 diabetes JO - Diabetes Metab Res Rev VL - 18 UR - https://doi.org/10.1002/dmrr.278 DO - 10.1002/dmrr.278 ID - Charpentier2002 ER - TY - JOUR AU - Riddle, M. C. PY - 2005 DA - 2005// TI - Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations JO - Endocrinol Metab Clin North Am VL - 34 UR - https://doi.org/10.1016/j.ecl.2004.12.002 DO - 10.1016/j.ecl.2004.12.002 ID - Riddle2005 ER - TY - JOUR PY - 2007 DA - 2007// TI - Medical guidelines for clinical practice for the management of diabetes mellitus JO - Endocr Pract VL - 13 ID - ref12 ER - TY - JOUR AU - Barnard, K. AU - Cox, M. E. AU - Green, J. B. PY - 2010 DA - 2010// TI - Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes JO - Diabetes Metab Syndr Obes VL - 3 ID - Barnard2010 ER - TY - JOUR AU - Schwarz, B. AU - Gouveia, M. AU - Chen, J. AU - Nocea, G. AU - Jameson, K. AU - Cook, J. AU - Krishnarajah, G. AU - Alemao, E. AU - Yin, D. AU - Sintonen, H. PY - 2008 DA - 2008// TI - Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2008.00886.x DO - 10.1111/j.1463-1326.2008.00886.x ID - Schwarz2008 ER - TY - JOUR PY - 2007 DA - 2007// TI - A report on the Fourth Mount Hood Challenge Meeting JO - Diabetes Care VL - 30 UR - https://doi.org/10.2337/dc07-9919 DO - 10.2337/dc07-9919 ID - ref15 ER - TY - JOUR AU - McEwan, P. AU - Peters, J. R. AU - Bergenheim, K. AU - Currie, C. J. PY - 2006 DA - 2006// TI - Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster) JO - Curr Med Res Opin VL - 22 UR - https://doi.org/10.1185/030079906X80350 DO - 10.1185/030079906X80350 ID - McEwan2006 ER - TY - JOUR AU - McEwan, P. AU - Bergenheim, K. AU - Yuan, Y. AU - Tetlow, A. P. AU - Gordon, J. P. PY - 2010 DA - 2010// TI - Assessing the relationship between computational speed and precision: a case study comparing an interpreted versus compiled programming language using a stochastic simulation model in diabetes care JO - Pharmacoeconomics VL - 28 UR - https://doi.org/10.2165/11535350-000000000-00000 DO - 10.2165/11535350-000000000-00000 ID - McEwan2010 ER - TY - JOUR AU - Clarke, P. M. AU - Gray, A. M. AU - Briggs, A. AU - Farmer, A. J. AU - Fenn, P. AU - Stevens, R. J. AU - Matthews, D. R. AU - Stratton, I. M. AU - Holman, R. R. PY - 2004 DA - 2004// TI - UK Prospective Diabetes Study (UKDPS) Group: A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) JO - Diabetologia VL - 47 UR - https://doi.org/10.1007/s00125-004-1527-z DO - 10.1007/s00125-004-1527-z ID - Clarke2004 ER - TY - BOOK PY - 2009 DA - 2009// TI - Guía de Práctica Clínica Nacional sobre Prevención PB - Diagnóstico y Tratamiento de la Diabetes Mellitus Tipo 2 Para el Primer Nivel de Atención CY - Buenos Aires ID - ref19 ER - TY - JOUR PY - 2010 DA - 2010// TI - Guía del tratamiento de la diabetes mellitus tipo 2 JO - Rev Soc Arg de Diabetes VL - 44 ID - ref20 ER - TY - BOOK PY - 2009 DA - 2009// TI - Clinical guideline 87. Type 2 diabetes: the management of type 2 diabetes (partial update) ID - ref21 ER - TY - JOUR AU - Gagliardino, J. J. PY - 2008 DA - 2008// TI - Resultados del International Diabetes Management Practices Study (IDMPS) en la Argentina en DMT2 [abstract]. Rev Soc Argent de JO - Diabetes VL - 42 ID - Gagliardino2008 ER - TY - CHAP AU - Gagliardino, J. J. PY - 2008 DA - 2008// TI - Results of International Diabetes Management Practices Study (IDMPS) in Argentina BT - 29th World Congress of Internal Medicine PB - Abstracts Book CY - Buenos Aires ID - Gagliardino2008 ER - TY - CHAP AU - Gagliardino, J. J. PY - 2008 DA - 2008// TI - International Diabetes Management Practices Study (IDMPS): Results in T2DM BT - 29th World Congress of Internal Medicine PB - Abstracts Book CY - Buenos Aires ID - Gagliardino2008 ER - TY - JOUR AU - Göke, B. AU - Gallwitz, B. AU - Eriksson, J. AU - Hellqvist, A. AU - Gause-Nilsson, I. PY - 2010 DA - 2010// TI - D1680C00001 Investigators. Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial JO - Int J Clin Pract VL - 64 UR - https://doi.org/10.1111/j.1742-1241.2010.02510.x DO - 10.1111/j.1742-1241.2010.02510.x ID - Göke2010 ER - TY - JOUR PY - 1998 DA - 1998// TI - Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)07019-6 DO - 10.1016/S0140-6736(98)07019-6 ID - ref26 ER - TY - JOUR AU - Klonoff, D. C. AU - Buse, J. B. AU - Nielsen, L. L. AU - Guan, X. AU - Bowlus, C. L. AU - Holcombe, J. H. AU - Wintle, M. E. AU - Maggs, D. G. PY - 2008 DA - 2008// TI - Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years JO - Curr Med Res Opin VL - 24 ID - Klonoff2008 ER - TY - JOUR AU - Ahrén, B. AU - Foley, J. E. AU - Ferrannini, E. AU - Matthews, D. R. AU - Zinman, B. AU - Dejager, S. AU - Fonseca, V. A. PY - 2010 DA - 2010// TI - Changes in prandial glucagon levels after 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc09-1867 DO - 10.2337/dc09-1867 ID - Ahrén2010 ER - TY - JOUR AU - White, J. PY - 2009 DA - 2009// TI - Efficacy and safety of incretin based therapies: clinical trial data JO - J Am Pharm Assoc VL - 49 UR - https://doi.org/10.1331/JAPhA.2009.09079 DO - 10.1331/JAPhA.2009.09079 ID - White2009 ER - TY - JOUR AU - Madsbad, S. PY - 2009 DA - 2009// TI - Lliraglutide effect and action in diabetes (LEAD TM) Trial JO - Expert Rev Endocrinol Metab VL - 4 UR - https://doi.org/10.1586/17446651.4.2.119 DO - 10.1586/17446651.4.2.119 ID - Madsbad2009 ER - TY - STD TI - Health Survey for England: Health Survey for England 2003- trends. Available from: accessed on 20 December 2009 http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/PublicationsAndStatistics/PublishedSurvey/HealthSurveyForEngland/HealthSurveyResults/DH_4098913; UR - http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/PublicationsAndStatistics/PublishedSurvey/HealthSurveyForEngland/HealthSurveyResults/DH_4098913 ID - ref31 ER - TY - JOUR AU - Clarke, P. AU - Gray, A. AU - Legood, R. AU - Briggs, A. AU - Holman, R. PY - 2003 DA - 2003// TI - The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) JO - Diabet Med VL - 20 UR - https://doi.org/10.1046/j.1464-5491.2003.00972.x DO - 10.1046/j.1464-5491.2003.00972.x ID - Clarke2003 ER - TY - JOUR AU - Currie, C. J. AU - McEwan, P. AU - Peters, J. R. AU - Patel, T. C. AU - Dixon, S. PY - 2005 DA - 2005// TI - The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects JO - Value Health VL - 8 UR - https://doi.org/10.1111/j.1524-4733.2005.00046.x DO - 10.1111/j.1524-4733.2005.00046.x ID - Currie2005 ER - TY - JOUR AU - Sherwyn, L. AU - Schwartz, M. D. PY - 2010 DA - 2010// TI - Treatment of elderly patients with type 2 diabetes mellitus: a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors JO - Am J Geriatr Pharmacother VL - 8 UR - https://doi.org/10.1016/j.amjopharm.2010.10.003 DO - 10.1016/j.amjopharm.2010.10.003 ID - Sherwyn2010 ER - TY - JOUR AU - Drucker, D. J. AU - Sherman, S. I. AU - Gorelick, F. S. AU - Bergenstal, R. M. AU - Sherwin, R. S. AU - Buse, J. B. PY - 2010 DA - 2010// TI - Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc09-1499 DO - 10.2337/dc09-1499 ID - Drucker2010 ER - TY - JOUR AU - Weisbrod, B. A. PY - 1991 DA - 1991// TI - The Health Care Quadrilemma: an essay on technological change, insurance, quality of care and cost containment JO - J Econ Literat VL - 29 ID - Weisbrod1991 ER - TY - JOUR AU - Burner, S. T. AU - Waldo, D. R. PY - 1995 DA - 1995// TI - National health expenditure projections,1994–2005 JO - Health Care Financ Rev VL - 16 ID - Burner1995 ER - TY - JOUR AU - Eddy, D. M. PY - 1996 DA - 1996// TI - Benefit language: criteria that will improve quality while reducing costs JO - JAMA VL - 275 UR - https://doi.org/10.1001/jama.1996.03530320074047 DO - 10.1001/jama.1996.03530320074047 ID - Eddy1996 ER - TY - JOUR AU - Eddy, D. M. PY - 1997 DA - 1997// TI - Investigational treatments: how strict should we be? JO - JAMA VL - 278 UR - https://doi.org/10.1001/jama.1997.03550030021009 DO - 10.1001/jama.1997.03550030021009 ID - Eddy1997 ER - TY - JOUR PY - 1979 DA - 1979// TI - The periodic health examination. Canadian Task Force on the Periodic Health Examination JO - Can Med Assoc J VL - 121 ID - ref40 ER - TY - BOOK PY - 1996 DA - 1996// TI - Guide to Clinical Preventive Services PB - Williams and Wilkins CY - Baltimore ID - ref41 ER - TY - BOOK AU - Sachs, J. D. PY - 2001 DA - 2001// TI - Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health PB - World Health Organization CY - Geneva ID - Sachs2001 ER - TY - BOOK AU - Baltussen, R. M. P. M. AU - Adam, T. AU - Tan-Torres Edejer, T. AU - Hutubessy, R. C. W. AU - Acharya, A. AU - Evans, D. B. AU - Murray, C. J. L. PY - 2003 DA - 2003// TI - Making choices in health: WHO guide to cost-effectiveness analysis PB - World Health Organization CY - Geneva ID - Baltussen2003 ER - TY - BOOK PY - 2011 DA - 2011// TI - World Bank ID - ref44 ER - TY - JOUR AU - Granström, O. AU - Bergenheim, K. AU - McEwan, P. AU - Sennfält, K. AU - Henriksson, M. PY - 2012 DA - 2012// TI - Cost-effectiveness of saxagliptin (Onglyza(®)) in type 2 diabetes in Sweden JO - Prim Care Diabetes VL - 6 UR - https://doi.org/10.1016/j.pcd.2011.09.003 DO - 10.1016/j.pcd.2011.09.003 ID - Granström2012 ER - TY - JOUR AU - Erhardt, W. AU - Bergenheim, K. AU - Duprat-Lomon, I. AU - McEwan, P. PY - 2012 DA - 2012// TI - Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis JO - Clin Drug Investig VL - 32 UR - https://doi.org/10.2165/11597060-000000000-00000 DO - 10.2165/11597060-000000000-00000 ID - Erhardt2012 ER -